483 Medpace Apr 2018

483 Medpace Apr 2018

Victoria Daddeo FDA$119.00 - Available Now

FDA investigators audited the Medpace - Cincinnati, OH, United States facility and issued inspectional observations (via FDA 483) on 20 Apr 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 20 Apr 2018
  • Location: Cincinnati, United States
  • FEI: 3009316555
Add To Cart